• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : AML With Myelodysplasia-related Features

AML With Myelodysplasia-related Features - 27 Studies Found

Completed : Characterization of the Mechanisms of Resistance to Azacitidine
: Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia
: 2010-09-27
Completed : Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Adult Acute Myeloid Le
    : 2006-04-11
    :
    • Drug: Azacitidine Given SC

Completed : Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • Adult Acute
    : 2012-03-28
    :
    • Drug: tosedostat Given PO

Completed : Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    : 2016-01-14
    :
    • Drug: Cytarabine Given IV

Completed : Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia With Multilineage Dyspla
    : 2010-08-02
    :
    • Drug: midostaurin Drug midosta

Recruiting : Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
:
  • Acute Biphenotypic Leukemia
  • Acute Erythroid Leukemia in Remission
  • Drug: Cyclophosphamide Given I

Recruiting : Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2014-03-11
    :
    • Drug: clofarabine Given IV

Completed : Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2014-02-24
    : Drug: eltrombopag olamine Given PO Other Names:
Terminated : Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2014-01-06
    :
    • Drug: cytarabine Given SC

Active, not recruiting : Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2012-10-08
    :
    • Drug: decitabine Given IV

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.